Display search results for ** instead (375 products)
10 Jan 2020  |  Asia Pacific
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
USD 8,500.00 save 15 %
28 Mar 2013  |  Latin America
Governmental Programs and Investments Stimulate the Market
This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...
USD 7,500.00 save 25 %
21 Apr 2016  |  Global
Shifting Demands from Key End-user Segments Unlocks New Growth Opportunities
Readers of the Lab Manager Magazine were invited to participate in an online survey in August 2015. To qualify, readers were required to play a role in their lab’s purchasing process, be familiar with their labs’ product budgets, and represent a lab that either uses or plans to use products in one or more of the 7 specified categories (instrume...
USD 6,000.00 save 25 %
04 Jul 2016  |  North America
The Next Generation of Cancer Therapies
Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...
USD 6,000.00 save 25 %
16 Aug 2016  |  North America
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...
USD 5,250.00 save 25 %
19 Apr 2013  |  Africa
Improved Diagnosis and Treatment Through Adoption of New Technologies
This research service presents the findings on the South African Medical Imaging Market. The research service presents an overview of the healthcare and medical imaging industry structure of the country. The market size and growth of the total medical imaging market, including five main device segments that characterise the market are presented. A ...
31 May 2013  |  Africa
Partnerships are Key to Effective Market Penetration
This research service presents an analysis of the magnetic resonance imaging market in Egypt. The market size and forecast for the total market are provided, which give an insight into the major factors that are driving the market, together with main restrains that are limiting growth. The market is further subdivided into three segments: low-field...
24 Aug 2015  |  Europe
Beyond Traditional Users, New Clinical Departments Grow Their Potential as Customer Segments
The growth of the ultrasound market is driven by the emerging clinical segment, as the established clinical segment has reached a saturation stage in select regions of NA and Western Europe. Growing awareness about the harmful effects of radiation exposure from other imaging modalities and delivery of sonogram services at the site of patients who a...
23 Jun 2021  |  Global
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
29 Jun 2021  |  North America
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Hospitals are under extreme pressure to reduce costs and become more profitable. Operating rooms (ORs) drive approximately 60% of revenue in the average hospital. The most critical issues entail finding new methods to reduce human error and improve the efficiency and quality of surgical care. Technology is now available to help hospitals reduce sur...